Ustekinumab for Crohn’s Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study

BACKGROUND AND AIMS: Ustekinumab is approved for the treatment of Crohn’s disease [CD]. Systematically registered prospective real-world data are scarce. We therefore aimed to study the effectiveness, safety and usage of ustekinumab for CD in everyday practice. METHODS: We prospectively enrolled CD...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Crohns Colitis
Main Authors: Biemans, Vince B C, van der Meulen - de Jong, Andrea E, van der Woude, Christine J, Löwenberg, Mark, Dijkstra, Gerard, Oldenburg, Bas, de Boer, Nanne K H, van der Marel, Sander, Bodelier, Alexander G L, Jansen, Jeroen M, Haans, Jeoffrey J L, Theeuwen, Rosaline, de Jong, Dirk, Pierik, Marie J, Hoentjen, Frank
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2020
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7142409/
https://ncbi.nlm.nih.gov/pubmed/31219157
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ecco-jcc/jjz119
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares